| Features: |
| MCT oils typically consist of medium-chain fatty acids such as caprylic acid (C8) and capric acid (C10). Here are some examples and sources of MCT oils: • Purified MCT Oil Products: – Commercial MCT oils (e.g., Nature’s Way MCT Oil, Now Sports MCT Oil) are available as dietary supplements and are often used in both nutritional and pharmaceutical applications. – These products are refined to contain mostly C8 and C10 fatty acids, which are known for their rapid digestion and absorption. • Coconut Oil (Fractionated): – Although traditional coconut oil contains a mix of medium-chain (and longer-chain) fatty acids, fractionated coconut oil has been processed to separate the medium-chain triglycerides (mainly C8 and C10). – This fractionated form is liquid at room temperature and can serve a similar purpose as purified MCT oil in formulations. - MCT oil is rapidly metabolized in the liver to produce ketone bodies, making it a common component of ketogenic diets. |
| 2642- | Flav, | QC, | Api, | KaempF, | MCT | In Vitro–In Vivo Study of the Impact of Excipient Emulsions on the Bioavailability and Antioxidant Activity of Flavonoids: Influence of the Carrier Oil Type |
| - | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
| 2643- | MCT, | Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism |
| - | Review, | Nor, | NA |
| 2644- | MCT, | The Effects of Medium-Chain Triglyceride Oil Supplementation on Endurance Performance and Substrate Utilization in Healthy Populations: A Systematic Review |
| - | Review, | Nor, | NA |
| 3895- | MCT, | How does coconut oil affect cognitive performance in alzheimer patients? |
| - | Human, | AD, | NA |
| 3896- | MCT, | Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study |
| - | Trial, | AD, | NA |
| 3897- | MCT, | The medium-chain fatty acid decanoic acid reduces oxidative stress levels in neuroblastoma cells |
| - | in-vitro, | AD, | NA |
| 3898- | MCT, | Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease |
| - | Review, | AD, | NA |
| 3899- | MCT, | COCONUT OIL: NON-ALTERNATIVE DRUG TREATMENT AGAINST ALZHEIMER´S DISEASE |
| - | Human, | AD, | NA |
| - | in-vitro, | AD, | NA |
| 3901- | MCT, | Potential of Capric Acid in Neurological Disorders: An Overview |
| - | Review, | AD, | NA |
| 3902- | MCT, | Effects of Caprylic Triglyceride on Cognitive Performance and Cerebral Glucose Metabolism in Mild Alzheimer’s Disease: A Single-Case Observation |
| - | Case Report, | AD, | NA |
| 3903- | MCT, | Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer’s disease |
| - | Case Report, | AD, | NA |
| 3904- | MCT, | Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer’s disease |
| - | Human, | AD, | NA |
| 3905- | MCT, | Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:333 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid